On December 15, 2022, the shareholder holding 5.9% of the shares submitted the proposal "Proposal on the Planned Sale of Partial Assets and Equity" to the Board of Directors with the objective to add the proposal to the 7th Extraordinary General Meeting of Shareholders in 2022. The background of the proposal is that YanAn Bikang Pharmaceutical planned to sell 100% equity of its subsidiary Shaanxi Bikang Pharmaceutical Group Co., Ltd. The transaction consists of the transferring of Shaanxi Bikang Pharmaceutical Group's assets to external parties, including Guangdong Yiyang Industrial Co., Ltd. and Dongguan Hengyuan Industrial Development Co., Ltd., for a total transaction price of 1 Chinese Yuan.